Pure Global AI
NCT06224504Completed

Clinical Effectiveness of Combining Mindfulness-Based Stress Reduction With Exercise Interventione

Combined Mindfulness-Based Stress Reduction and Exercise Intervention for Improving Psychological Well-being in Chinese Patients With Non-Small Cell Lung Cancer
Shanxi Bethune HospitalClinicalTrials.govbehavioral
Study focus
Drug/Device/Intervention
routine health education
Study type
Interventional
Intervention type
behavioral
Sponsor & location
Primary sponsor
Shanxi Bethune Hospital
Location
Taiyuan, China
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2021
End date
Jan 01, 2024
Enrollment
60 participants
Primary outcome

SAS score,SAS score,SAS score,SDS score,SDS score,SDS score,BSRS-5 score,BSRS-5 score,BSRS-5 score,PSQI score,PSQI score,PSQI score

Summary

This study is to assess the clinical effectiveness of combining Mindfulness-Based Stress
 Reduction (MBSR) with exercise intervention in improving anxiety, depression, sleep quality,
 and mood regulation in Chinese patients with non-small cell lung cancer (NSCLC).The control
 group received conventional psychological nursing care, while the intervention group received
 a combination of MBSR and exercise therapy. Pre- and post-treatment scores of anxiety,
 depression, sleep quality, and the BSRS-5 were compared.

ICD-10 classifications
Secondary malignant neoplasm of lungMalignant neoplasm: Lower lobe, bronchus or lungMalignant neoplasm: Middle lobe, bronchus or lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm of bronchus and lung
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06224504
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06224504 through Pure Global AI's free database. This phase not specified trial is sponsored by Shanxi Bethune Hospital and is currently Completed. The study focuses on Non-Small Cell Lung Cancer. Target enrollment is 60 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.